Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer
- Авторлар: Bespalov V.G.1,2, Vyshinskaya E.A.1, Vasil’eva I.N.1,2, Semenov A.L.1,2, Maidin M.A.1, Barakova N.V.2, Stukov A.N.1
- 
							Мекемелер: 
							- Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
- International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
 
- Шығарылым: Том 162, № 3 (2017)
- Беттер: 383-386
- Бөлім: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/238232
- DOI: https://doi.org/10.1007/s10517-017-3621-5
- ID: 238232
Дәйексөз келтіру
Аннотация
Antitumor efficiencies of cytostatics dioxadet, cisplatin, mitomycin C, melphalan, and paclitaxel after a single intraperitoneal or intravenous injection in doses of 1.5, 4, 1.5, 2, and 5 mg/kg, respectively, were studied on the model of transplanted ovarian tumor in 124 rats. The antitumor effects were evaluated by the increase in median survival. Dioxadet, cisplatin, and melphalan injected intraperitoneally significantly prolonged the lifespan median – by 79, 88, and 114%, respectively, and were in fact ineffective, when injected intravenously. Intraperitoneal mitomycin C prolonged lifespan median by just 35%, intravenous – by 152%. Paclitaxel injected intraperitoneally and intravenously prolonged the lifespan median by 45 and 81%, respectively.
Авторлар туралы
V. Bespalov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg; St. Petersburg						
E. Vyshinskaya
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg						
I. Vasil’eva
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
							Хат алмасуға жауапты Автор.
							Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg; St. Petersburg						
A. Semenov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation; International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg; St. Petersburg						
M. Maidin
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg						
N. Barakova
International Research Centre “Biotechnologies of the Third Millennium”, ITMO University (St. Petersburg National Research University of Information Technologies, Mechanics and Optics
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg						
A. Stukov
Research Laboratory of Cancer Chemoprophylaxis and Oncopharmacology, I. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation
														Email: iravasilyeva@hotmail.com
				                					                																			                												                	Ресей, 							St. Petersburg						
Қосымша файлдар
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  
  
  Мақаланы E-mail арқылы жіберу
			Мақаланы E-mail арқылы жіберу  Ашық рұқсат
		                                Ашық рұқсат Рұқсат берілді
						Рұқсат берілді Тек жазылушылар үшін
		                                		                                        Тек жазылушылар үшін
		                                					